C4 Therapeutics, Inc. Public Float
C4 Therapeutics, Inc. (CCCC) had Public Float of $100.05 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $100.05M.
- 2024-06-30: Entity Public Float $306.04M.
- 2023-06-30: Entity Public Float $129.57M.
- 2022-06-30: Entity Public Float $201.26M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $100.05M 10-K · filed 2026-02-26 |
| 2024-06-30 | $306.04M 10-K · filed 2025-02-27 |
| 2023-06-30 | $129.57M 10-K · filed 2024-02-22 |
| 2022-06-30 | $201.26M 10-K · filed 2023-02-23 |
| 2021-06-30 | $1.28B 10-K · filed 2022-02-24 |
| 2020-06-30 | $0.00 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |